Jeff Yass’s Precision BioSciences DTIL Stock Holding History

Jeff Yass’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-517	Closed	-$48K	–	13095
2022 Q1	$48K	Sell	517 -1,266	-71%	-$172K	﹤0.01%	12329
2021 Q4	$396K	Sell	1,783 -107	-6%	-$29.9K	﹤0.01%	9805
2021 Q3	$654K	Sell	1,890 -1,033	-35%	-$350K	﹤0.01%	8694
2021 Q2	$1.1M	Buy	2,923 +256	+10%	+$76.9K	﹤0.01%	7507
2021 Q1	$828K	Sell	2,667 -1,373	-34%	-$481K	﹤0.01%	8217
2020 Q4	$1.01M	Buy	4,040 +3,663	+972%	+$898K	﹤0.01%	6705
2020 Q3	$70K	Sell	377 -1,613	-81%	-$321K	﹤0.01%	10091
2020 Q2	$497K	Buy	1,990 +30	+2%	+$6.57K	﹤0.01%	7372
2020 Q1	$355K	Buy	1,960 +1,023	+109%	+$268K	﹤0.01%	7651
2019 Q4	$390K	Buy	+937	New	+$294K	﹤0.01%	7477

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Jeff Yass's DTIL Position: Q2 2026 in Review

Jeff Yass reduced its Precision BioSciences (DTIL) stake by 49% in Q2 2026, selling an estimated $222K and leaving 32,897 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #11377.

Jeff Yass first reported a position in DTIL in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.78M in Q2 2021. 94 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Jeff Yass held 32,897 shares of Precision BioSciences worth $259K as of Q2 2026.
Jeff Yass sold 31,565 Precision BioSciences shares in Q2 2026, an estimated $222K.
Precision BioSciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11377 holding.
Jeff Yass first reported a position in Precision BioSciences in Q4 2019 and has held it in 19 quarters since.
Jeff Yass's Precision BioSciences position peaked at $1.78M in Q2 2021.
94 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.